Please login to the form below
prescription drugs
This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.
ICER to review the role of health insurers in determining patient access to prescription drugs
coverage for drugs and, in addition, promote the positive linkage of fair pricing with fair access that will advance the best interests of patients and the health system.'. ... These 28 specific drugs will have been previously found by ICER to be priced
Latest news
-
Purdue to pay over $8bn to settle opioid-related criminal claims
Filings made by 49 states in the US allege that Purdue pushed prescription painkillers on doctors and patients while knowingly minimising the harmful side effects of the drugs. ... Purdue manufactured the prescription opioid painkiller OxyContin, which
-
Lilly joins new Medicare scheme to reduce insulin prices
That includes recent draft guidance published by the Trump administration which would allow states in the US to import prescription drugs from Canada to try to reduce cost, although that plan ... excludes biologics such as insulin as well as intravenous
-
AbbVie/Allergan merger faces renewed public opposition despite divestments
AbbVie. They also highlighted AbbVie’s use of controversial “rebate walls” around its blockbuster immunology products – including Humira and Skyrizi – which the groups say “lead to higher prescription drug prices” and ... prevents “rival
-
Lilly extends range of cut-price insulins in the US
list price of the branded drugs – will be available in April, according to the company. ... Last month, the Trump administration published draft guidance which would allow states in the US to import prescription drugs from Canada to try to reduce
-
GSK, Pfizer and Sanofi among drugmakers planning price hikes in US
range. The price increases come amid intense public and political discourse over prescription drug prices in the US. ... The draft guidance would allow states in the US to import prescription drugs from Canada, as part of cost-saving efforts to combat
Purdue to pay over $8bn to settle opioid-related criminal claims
Lilly joins new Medicare scheme to reduce insulin prices
AbbVie/Allergan merger faces renewed public opposition despite divestments
Lilly extends range of cut-price insulins in the US
GSK, Pfizer and Sanofi among drugmakers planning price hikes in US
More from news
Approximately 3 fully matching, plus 181 partially matching documents found.
Latest Intelligence
-
Eliminating pharmaceutical rebates, is this déjà vu?
Due to consolidation in the industry, most prescription drug benefits, including Medicare Part D benefits, are administered by several significant PBMs. ... It also provides more transparency to patients and other stakeholders about the actual costs of
-
BRIC markets
prescription drugs is a problem,” he continued. ... Drugs that aren’t listed may maintain a higher price and the lack of access may not necessarily be a negative for them.”.
-
Drug launches to watch in 2019
11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... Now there is a growing need for treatments which can
-
Behaviour change – a missing ingredient?
There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or
-
US health reforms
In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs
Eliminating pharmaceutical rebates, is this déjà vu?
BRIC markets
Drug launches to watch in 2019
Behaviour change – a missing ingredient?
More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.
Latest appointments
-
Keith Webber leaves FDA for Perrigo
Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs. ... This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.
-
Genzyme’s Richard Moscicki joins FDA
prescription-only drugs available in the US.
Keith Webber leaves FDA for Perrigo
Genzyme’s Richard Moscicki joins FDA
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Behaviour change – is there something missing?
There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or
-
How to build an online medical information service that resonates with your customers
However, as an increasing number of drugs have come off patent, there is a growing need for clinical and scientific medical information.Now more and more pharmaceutical companies are investing in ... Manufacturers are responsible for the way they respond
-
PEGASUS JOINS ASHFIELD HEALTHCARE COMMUNICATIONS
Sharp is also a world leader in ’Track and Trace’ serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability. .
-
How to design patient services with social media within the ABPI code guidelines
When designing digital services and informational materials for prescription drugs or services, there are unique considerations that must be taken around how that information is accessed and used. ... The code explains how use of social media to discuss
-
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?
drugs, whilst boosting generic drug prescription and supporting the domestic drug industry. ... Following the Act, any drug registered as a “similares” have to meet the same bioequivalence standards as generic drugs.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital account director
-
Competitive
-
Digital strategist
-
Competitive
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Events Executive
-
Depending on Experience
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- AZ’s PNH therapy Ultomiris wins EU backing to expand use for children
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Straight outta lockdown – what’s next for flexible working?
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
No results were found
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
